Ascendis Health Limited (ASC.JO)
ZAc 78.0
(0.0%)
ZAc 78.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.1 Million | -140.38 Million | -93.58 Million | 646.47 Million | 224.84 Million | 196.59 Million |
| Net Income | 57.29 Million | -286.24 Million | -758.08 Million | -1.61 Billion | -902.57 Million | -4.75 Billion |
| Depreciation & Amortization | 57.04 Million | 76.4 Million | 79.82 Million | 100.98 Million | 381.42 Million | 220.79 Million |
| Deferred income taxes | -7.46 Million | -12.42 Million | -42.32 Million | 102.65 Million | - | 4.68 Billion |
| Stock-based compensation | - | - | - | - | - | 1.52 Million |
| Change in working capital | 9.12 Million | -15.37 Million | -86.15 Million | 83.32 Million | -487.91 Million | -311.93 Million |
| Other non-cash items | -131.57 Million | 84.82 Million | 670.82 Million | 2.07 Billion | 1.23 Billion | 352.95 Million |
| Investing Cash Flow | -20.32 Million | 475.72 Million | 1.04 Billion | -268.05 Million | 54.88 Million | -533.1 Million |
| Investments in PPE | -37.09 Million | -35.84 Million | -55.8 Million | -39.71 Million | -325.67 Million | -392.25 Million |
| Acquisitions | 27.9 Million | 432.2 Million | 1.18 Billion | 170.2 Million | 423.99 Million | -33.41 Million |
| Investment purchases | -5.61 Million | -432.2 Million | - | 23.16 Million | -41.56 Million | -6.32 Million |
| Sales/Maturities of investments | - | 49.69 Million | - | 2.63 Million | -97.45 Million | 33.41 Million |
| Other Investing Activities | 16.76 Million | 461.88 Million | -88.38 Million | -424.33 Million | 95.57 Million | -134.51 Million |
| Financing Cash Flow | -31.13 Million | -450.52 Million | -1.27 Billion | -266.87 Million | -364.68 Million | 103.63 Million |
| Debt repayment | -31.13 Million | -540.12 Million | -1.13 Billion | -86.79 Million | -960.45 Million | -387.59 Million |
| Dividends payments | - | - | - | - | - | -2 Million |
| Common Stock Repurchased | - | - | -2.12 Million | - | - | -5.4 Million |
| Common Stock Issuance | - | 101.53 Million | - | - | - | 550.26 Million |
| Other Financing Activities | 1000.00 | -11.93 Million | -135.63 Million | -180.07 Million | 595.76 Million | -51.63 Million |
| Accounts receivables | -16.68 Million | 4.63 Million | -62.6 Million | 73.26 Million | 108.84 Million | 6.41 Million |
| Accounts payables | -73.39 Million | 99.21 Million | -32.61 Million | -71.45 Million | 114.9 Million | 64.5 Million |
| Inventory | 33.4 Million | -106.48 Million | 17.34 Million | 31.17 Million | -229.67 Million | -219.28 Million |
| Other working capital | -7.58 Million | -12.74 Million | -8.28 Million | 50.34 Million | -481.99 Million | -163.56 Million |
| Cash at beginning of period | 102.23 Million | 213.02 Million | 365.91 Million | 343.98 Million | 397.11 Million | 686.62 Million |
| Cash at end of period | 42.66 Million | 102.23 Million | 213.02 Million | 365.91 Million | 343.98 Million | 265.01 Million |
| Capital Expenditure | -37.09 Million | -35.84 Million | -55.8 Million | -39.71 Million | -325.67 Million | -392.25 Million |
| Effect of forex changes on cash | - | 4.4 Million | -1.95 Million | 24.11 Million | 37.3 Million | -166 Thousand |
| Net cash flow / Change in cash | -59.56 Million | -110.78 Million | -152.89 Million | 21.92 Million | -53.13 Million | -421.6 Million |
| Free Cash Flow | -45.2 Million | -176.23 Million | -149.39 Million | 606.75 Million | -100.82 Million | -195.66 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.11 Million | 41.57 Million | -11.11 Million | 63.8 Million | 39.76 Million | -286.24 Million |
| Depreciation & Amortization | 13.32 Million | 57.04 Million | 13.32 Million | 56.5 Million | 15.19 Million | 76.4 Million |
| Deferred income taxes | -7.46 Million | - | - | - | - | -12.42 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.56 Million | - | 4.56 Million | - | - | -15.37 Million |
| Other non-cash items | 2.04 Million | 10.5 Million | 2.04 Million | -33.04 Million | -67.83 Million | 84.82 Million |
| Investing Cash Flow | -14.01 Million | -23.45 Million | -14.01 Million | 7.69 Million | 3.84 Million | 475.72 Million |
| Investments in PPE | -10.03 Million | -45.8 Million | -10.03 Million | -17.81 Million | -8.51 Million | -35.84 Million |
| Acquisitions | 2.39 Million | 27.9 Million | - | 25.5 Million | - | 432.2 Million |
| Investment purchases | -5.61 Million | -5.61 Million | - | - | - | -432.2 Million |
| Sales/Maturities of investments | - | - | - | - | - | 49.69 Million |
| Other Investing Activities | -3.97 Million | 54 Thousand | -3.97 Million | 12.36 Million | 12.36 Million | 461.88 Million |
| Financing Cash Flow | -3.38 Million | -31.13 Million | -3.38 Million | -24.37 Million | -12.18 Million | -450.52 Million |
| Debt repayment | -1000.00 | -20.29 Million | - | -20.29 Million | - | -540.12 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 101.53 Million |
| Other Financing Activities | -3.38 Million | - | -3.38 Million | -12.18 Million | -12.18 Million | -11.93 Million |
| Accounts receivables | -8.34 Million | - | -8.34 Million | - | - | 4.63 Million |
| Accounts payables | - | - | - | - | - | 99.21 Million |
| Inventory | 16.7 Million | - | 16.7 Million | - | - | -106.48 Million |
| Other working capital | -3.79 Million | - | -3.79 Million | - | - | -12.74 Million |
| Cash at beginning of period | 80.02 Million | 102.23 Million | - | 102.23 Million | - | 213.02 Million |
| Cash at end of period | 42.66 Million | 42.66 Million | -8.57 Million | 80.02 Million | -21.21 Million | 102.23 Million |
| Capital Expenditure | -10.03 Million | -45.8 Million | -10.03 Million | -17.81 Million | -8.51 Million | -35.84 Million |
| Effect of forex changes on cash | - | - | - | 20.22 Million | - | 4.4 Million |
| Net cash flow / Change in cash | -37.36 Million | -59.56 Million | -8.57 Million | -22.2 Million | -21.21 Million | -110.78 Million |
| Free Cash Flow | -1.21 Million | -50.77 Million | -1.21 Million | -43.56 Million | -21.38 Million | -176.23 Million |
CMBT
9837
ROYUF
MCY
BAS
IVL